Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-PD II: Sustaining Remission of Psychotic Depression
NCT01427608Phase 4Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2011
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of olanzapine in psychotic depression, sponsored by Weill Cornell Medicine. Started Oct 2011; status: completed.
02
Drugs
olanzapine
03
Conditions
psychotic depression
Beyond the preview
Go deeper on NCT01427608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01427608.